companydata.dkcompanydata.dk

ACE BIOSCIENCES ApS: Financial statements 2018

CVR: 25616715

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

ACE BIOSCIENCES ApS (CVR 25616715) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 14,243,000 and a net result of DKK 658,000 compared with DKK 545,000 the year before. That is a decrease of 20.7% compared with the year before. The profit margin was 4.6%. Equity in the 2018 report amounted to DKK 15,179,000. The solvency ratio was 83%.

Revenue
DKK 14,243,000
Gross Profit
DKK 14,243,000
Profit/Loss
DKK 658,000
Equity
DKK 15,179,000
Total Assets
DKK 18,284,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201814.2 mio.14.2 mio.658 t.15.2 mio.-
201718 mio.18 mio.545 t.13.2 mio.-
201621 mio.21 mio.8.4 mio.12.2 mio.-
2015--9 mio.414 t.3.8 mio.-
2014--6.9 mio.28.5 mio.3.4 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

ACE BIOSCIENCES ApS: The 2017 annual report is outApr 19, 2018

ACE BIOSCIENCES ApS has published its annual report for 2017. Revenue came to DKK 17,972,000, and the net result was DKK 545,000.

About ACE BIOSCIENCES ApS

ACE BIOSCIENCES ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 11 September 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ACE BIOSCIENCES A/S and SCSK 5502 ApS. The company has 3 employees (2009). In 2018, the company reported revenue of DKK 14,243,000 and a net result of DKK 658,000 compared with DKK 545,000 the year before. Equity in the 2018 report amounted to DKK 15,179,000.

Source: annual report 2018, Danish Business Authority

Other financial years